General effect of low-dose tamsulosin (0.2 mg) as a first-line treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia: a systematic review and meta-analysis. [electronic resource]
- Current medical research and opinion Feb 2015
- 353-65 p. digital
Asia Humans Lower Urinary Tract Symptoms--drug therapy Male Prostatic Hyperplasia--complications Quality of Life Randomized Controlled Trials as Topic Sulfonamides--therapeutic use Tamsulosin Treatment Outcome Urological Agents--therapeutic use